Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
UTime ( (WTO) ) has provided an announcement.
On December 31, 2025, UTime Limited announced that its Hong Kong subsidiary, UTime Technology (HK) Company Limited, signed a nearly US$10 million smart health device procurement agreement with Denver-based Tumu Vertex LLC, marking a major commercial milestone and a strategic step into the North American medical-grade smart wearable market. Under the sales agreement, Tumu Vertex placed an initial order for 50,000 premium smart health wearables, including UT-168 BT and UT-368 4G blood pressure watches as well as UR08 and UR01 smart rings, with first deliveries scheduled to begin in the first quarter of 2026 under FOB Hong Kong terms and joint quality control procedures. The deal highlights growing demand for continuous health monitoring solutions amid aging and more health-conscious populations and is expected to strengthen UTime’s position in consumer electronics while laying groundwork for its expansion into higher-value medical-technology applications.
More about UTime
UTime Limited (Nasdaq: WTO) is a China-based global technology company engaged in the design, development, production, sales and brand operation of mobile devices and smart wearable devices. The company focuses on providing cost-effective products to a broad customer base in China and international markets, and is increasingly targeting the smart health wearable segment as part of its consumer electronics and medical-technology positioning.
Average Trading Volume: 832,762
Technical Sentiment Signal: Sell
Current Market Cap: $1.78M
For an in-depth examination of WTO stock, go to TipRanks’ Overview page.